Literature DB >> 6394505

The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas.

C Jorup-Rönström, S Britton, A Gavlevik, K Gunnarsson, A C Redman.   

Abstract

Oral versus intravenous antibiotic therapy of severe erysipelas was compared in a controlled trial of 60 patients. No clinical benefit of intravenous therapy was found, as evaluated by fever duration, hospital stay and sick leave. Untoward reactions were comparable between the groups. No difference in recurrence was found. The difference in administration time and drug cost was considerable. It is therefore suggested that erysipelas without complications should be treated orally.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6394505     DOI: 10.1007/BF01645222

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  25 in total

1.  Experimental infusion thrombophlebitis. Importance of the infusion rate.

Authors:  I Hessov; M Bojsen-Møller
Journal:  Eur J Intensive Care Med       Date:  1976-09

2.  Heparin in the prevention of infusion phlebitis. A double-blind controlled study.

Authors:  H W Daniell
Journal:  JAMA       Date:  1973-12-10       Impact factor: 56.272

3.  High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children.

Authors:  Y J Bryson; J D Connor; M LeClerc; S T Giammona
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

4.  Factors influencing serum antibody responses in streptococcal pyoderma.

Authors:  A L Bisno; K E Nelson; P Waytz; J Brunt
Journal:  J Lab Clin Med       Date:  1973-03

5.  Further studies on the treatment of streptococcal skin infection.

Authors:  C W Derrick; H C Dillon
Journal:  J Pediatr       Date:  1970-10       Impact factor: 4.406

6.  Oral antibiotic therapy for acute aspiration lung abscess.

Authors:  W Weiss
Journal:  Tex Med       Date:  1978-05

7.  Skin infections and acute nephritis in American Indian children.

Authors:  B F Anthony; L V Perlman; L W Wannamaker
Journal:  Pediatrics       Date:  1967-02       Impact factor: 7.124

8.  The influence of the site of infection on the immune response to group A streptococci.

Authors:  E L Kaplan; B F Anthony; S S Chapman; E M Ayoub; L W Wannamaker
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

9.  Blood coagulation and fibrinolytic systems in patients with erysipelas and necrotizing fasciitis.

Authors:  B Sverdrup; M Blombäck; E Borglund; H Hammar
Journal:  Scand J Infect Dis       Date:  1981

10.  Cost-effective antibiotic prescribing.

Authors:  R Gleckman; N M Gantz
Journal:  Pharmacotherapy       Date:  1983 Jul-Aug       Impact factor: 4.705

View more
  8 in total

1.  Recurrent erysipelas: predisposing factors and costs of prophylaxis.

Authors:  C Jorup-Rönström; S Britton
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

2.  Hospital costs for patients with lower extremity cellulitis: a retrospective population-based study.

Authors:  Douglas Challener; Jasmine Marcelin; Sue Visscher; Larry Baddour
Journal:  Hosp Pract (1995)       Date:  2017-09-27

3.  Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial.

Authors:  Philippe Bernard; Olivier Chosidow; Loïc Vaillant
Journal:  BMJ       Date:  2002-10-19

4.  Skin concentrations of phenoxymethylpenicillin in patients with erysipelas.

Authors:  A C Sjöblom; J Bruchfeld; B Eriksson; C Jorup-Rönström; K Karkkonen; A S Malmborg; M Lindqvist
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

Review 5.  Cellulitis and erysipelas.

Authors:  Andrew D Morris
Journal:  BMJ Clin Evid       Date:  2008-01-02

6.  Antibiotic prophylaxis in recurrent erysipelas.

Authors:  A C Sjöblom; B Eriksson; C Jorup-Rönström; K Karkkonen; M Lindqvist
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

Review 7.  Interventions for cellulitis and erysipelas.

Authors:  Sally A Kilburn; Peter Featherstone; Bernie Higgins; Richard Brindle
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

8.  Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections.

Authors:  Sudipta Kumar Dey; Amal Kanti Das; Sumit Sen; Avijit Hazra
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.